227 related articles for article (PubMed ID: 11205156)
1. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
Werner P; Pitt D; Raine CS
J Neural Transm Suppl; 2000; (60):375-85. PubMed ID: 11205156
[TBL] [Abstract][Full Text] [Related]
2. Glutamate excitotoxicity in a model of multiple sclerosis.
Pitt D; Werner P; Raine CS
Nat Med; 2000 Jan; 6(1):67-70. PubMed ID: 10613826
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
4. The link between excitotoxic oligodendroglial death and demyelinating diseases.
Matute C; Alberdi E; Domercq M; Pérez-Cerdá F; Pérez-Samartín A; Sánchez-Gómez MV
Trends Neurosci; 2001 Apr; 24(4):224-30. PubMed ID: 11250007
[TBL] [Abstract][Full Text] [Related]
5. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter.
Tekkök SB; Goldberg MP
J Neurosci; 2001 Jun; 21(12):4237-48. PubMed ID: 11404409
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis and glutamate.
Groom AJ; Smith T; Turski L
Ann N Y Acad Sci; 2003 May; 993():229-75; discussion 287-8. PubMed ID: 12853317
[TBL] [Abstract][Full Text] [Related]
7. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.
Domercq M; Etxebarria E; Pérez-Samartín A; Matute C
Glia; 2005 Oct; 52(1):36-46. PubMed ID: 15892126
[TBL] [Abstract][Full Text] [Related]
8. Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation.
Evonuk KS; Doyle RE; Moseley CE; Thornell IM; Adler K; Bingaman AM; Bevensee MO; Weaver CT; Min B; DeSilva TM
Sci Adv; 2020 Jan; 6(2):eaax5936. PubMed ID: 31934627
[TBL] [Abstract][Full Text] [Related]
9. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity.
Takahashi JL; Giuliani F; Power C; Imai Y; Yong VW
Ann Neurol; 2003 May; 53(5):588-95. PubMed ID: 12730992
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
Smith T; Groom A; Zhu B; Turski L
Nat Med; 2000 Jan; 6(1):62-6. PubMed ID: 10613825
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease.
Kanwar JR
Curr Med Chem; 2005; 12(25):2947-62. PubMed ID: 16378498
[TBL] [Abstract][Full Text] [Related]
13. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
Follett PL; Deng W; Dai W; Talos DM; Massillon LJ; Rosenberg PA; Volpe JJ; Jensen FE
J Neurosci; 2004 May; 24(18):4412-20. PubMed ID: 15128855
[TBL] [Abstract][Full Text] [Related]
14. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord.
Xu GY; Hughes MG; Ye Z; Hulsebosch CE; McAdoo DJ
Exp Neurol; 2004 Jun; 187(2):329-36. PubMed ID: 15144859
[TBL] [Abstract][Full Text] [Related]
15. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity.
McDonald JW; Althomsons SP; Hyrc KL; Choi DW; Goldberg MP
Nat Med; 1998 Mar; 4(3):291-7. PubMed ID: 9500601
[TBL] [Abstract][Full Text] [Related]
16. Myelin-associated glycoprotein activation triggers glutamate uptake by oligodendrocytes in vitro and contributes to ameliorate glutamate-mediated toxicity in vivo.
Vivinetto AL; Castañares C; Garcia-Keller C; Moyano AL; Falcon C; Palandri A; Rozés-Salvador V; Rojas JI; Patrucco L; Monferran C; Cancela L; Cristiano E; Schnaar RL; Lopez PHH
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166324. PubMed ID: 34954343
[TBL] [Abstract][Full Text] [Related]
17. Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms.
Rosin C; Bates TE; Skaper SD
J Neurochem; 2004 Sep; 90(5):1173-85. PubMed ID: 15312172
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage.
Werner P; Pitt D; Raine CS
Ann Neurol; 2001 Aug; 50(2):169-80. PubMed ID: 11506399
[TBL] [Abstract][Full Text] [Related]
19. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Gilgun-Sherki Y; Panet H; Melamed E; Offen D
Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941
[TBL] [Abstract][Full Text] [Related]
20. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
